These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 initiates an innate immune response to lipopolysaccharide in human conjunctival epithelial cells. Chung SH; Kweon MN; Lee HK; Choi SI; Yang JY; Kim EK Exp Eye Res; 2009 Jan; 88(1):49-56. PubMed ID: 18951893 [TBL] [Abstract][Full Text] [Related]
9. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allam JP; Stojanovski G; Friedrichs N; Peng W; Bieber T; Wenzel J; Novak N Allergy; 2008 Jun; 63(6):720-7. PubMed ID: 18445186 [TBL] [Abstract][Full Text] [Related]
10. Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release. Filì L; Ferri S; Guarna F; Sampognaro S; Manuelli C; Liotta F; Cosmi L; Matucci A; Vultaggio A; Annunziato F; Maggi E; Guarna A; Romagnani S; Parronchi P J Allergy Clin Immunol; 2006 Aug; 118(2):511-7. PubMed ID: 16890779 [TBL] [Abstract][Full Text] [Related]
11. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. Didierlaurent AM; Morel S; Lockman L; Giannini SL; Bisteau M; Carlsen H; Kielland A; Vosters O; Vanderheyde N; Schiavetti F; Larocque D; Van Mechelen M; Garçon N J Immunol; 2009 Nov; 183(10):6186-97. PubMed ID: 19864596 [TBL] [Abstract][Full Text] [Related]
12. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways. Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044 [TBL] [Abstract][Full Text] [Related]
13. Th1 polarization of CD4+ T cells by Toll-like receptor 3-activated human microglia. Jack CS; Arbour N; Blain M; Meier UC; Prat A; Antel JP J Neuropathol Exp Neurol; 2007 Sep; 66(9):848-59. PubMed ID: 17805015 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025 [TBL] [Abstract][Full Text] [Related]
15. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells. Ge W; Ma X; Li X; Wang Y; Li C; Meng H; Liu X; Yu Z; You S; Qiu L Leuk Res; 2009 Jul; 33(7):948-57. PubMed ID: 19233469 [TBL] [Abstract][Full Text] [Related]
16. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells. Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X Vet Res; 2008; 39(2):11. PubMed ID: 18096120 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of cell surface Toll-like receptor 4-MD2 expression on dendritic epidermal T cells after the emigration from epidermis during cutaneous inflammation. Shimura H; Nitahara A; Ito A; Tomiyama K; Ito M; Kawai K J Dermatol Sci; 2005 Feb; 37(2):101-10. PubMed ID: 15659328 [TBL] [Abstract][Full Text] [Related]
18. Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid. Zhang Q; Qian FH; Liu H; Zhou LF; Huang M; Zhang XL; Yin KS Chin Med J (Engl); 2008 Feb; 121(3):205-12. PubMed ID: 18298910 [TBL] [Abstract][Full Text] [Related]
19. Immune mechanisms of allergen-specific sublingual immunotherapy. Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190 [TBL] [Abstract][Full Text] [Related]
20. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]